Training the scientists and engineers of the future requires academic spaces that are as much as a story taller and 1,000 sf bigger than in the past, and better-equipped to support entrepreneurship, industry partnerships, and hands-on learning. In addition to the standard makerspaces—with metal shops, machining labs, woodshops, prototyping, and 3D printing—students are also experimenting with wind tunnels and large water tanks.
McCord Development is planning to construct BioHub Two in northeast Houston. Comprising 500,000 sf of lab, office, and cGMP manufacturing space, the 45-acre campus will accommodate a total of seven structures offering built-to-suit environments for private companies. This dynamic nexus of innovation and discovery will catalyze synergies with San Jacinto College's planned Biotech Training Center, which will be located nearby.
Ultragenyx opened a 110,000-sf gene therapy manufacturing facility in June of 2023 in Bedford, Mass. Advancing the creation of innovative treatments for rare genetic diseases, the sophisticated structure enables the large-scale manufacture of clinical-stage materials and approved products based on adeno-associated viral vectors (AAV). The highly efficient building integrates the company's proprietary Pinnacle PCL™ (producer cell line) platform which delivers optimal quality and scalability while reducing costs.
Clemson University broke ground in May of 2023 on the $130 million Advanced Materials Innovation Complex in Clemson, S.C. Housing the Department of Materials Science and Engineering, the 143,000-sf center will also accommodate select faculty from the Department of Chemistry and the Department of Chemical and Biomedical Engineering as they explore interdisciplinary synergies and endeavors. Collaborative research suites will enable teams of investigators to discover new technologies for advanced manufacturing, energy, and health.
The International Society for Pharmaceutical Engineering (ISPE) has announced the 2023 Facility of the Year Awards category winners. The awards include:
Savannah River National Laboratory began construction in April of 2023 on a $50 million facility located on the campus of the University of South Carolina Aiken. Designed by Page and STOA Architects, the Advanced Manufacturing Collaborative (AMC) will enable the Department of Energy's Office of Environmental Management to engage in shared discovery with academic institutions, industry partners, and government agencies at the city, state, and federal level.
Moderna will break ground in mid-2023 on a £150 million complex for the creation of mRNA vaccines and therapeutics in the United Kingdom. Located on the Harwell Campus in Oxfordshire, the Moderna Innovation and Technology Centre (MITC) will comprise two 145,000-sf buildings. The Drug Substance Manufacturing Unit will leverage next-generation automation systems to produce high volumes of vaccine materials, accompanied by an early-stage R&D hub that will support clinical trials.
Genentech broke ground in February of 2023 on a $280 million biologics manufacturing center in Oceanside, Calif. The small-batch facility will utilize single-use bioreactors for the commercial production of innovative therapeutics such as personalized medicines and treatments for rare diseases. Featuring advanced automation platforms and digital technologies, the 84,000-sf plant will leverage in-house process improvements to achieve increased flexibility, speed, and output.
Missouri University of Science and Technology will begin construction in late summer of 2023 on a $53.4 million manufacturing innovation hub in Rolla. Designed by Perkins&Will and Mackey Mitchell Architects, the Missouri Protoplex will be the headquarters of a statewide ecosystem where experts, innovators, business owners, and educators develop new production methods and technologies.
The Centre for Process Innovation (CPI) opened the Medicines Manufacturing Innovation Centre in December of 2022 in Inchinnan in the United Kingdom. Situated in the heart of the Advanced Manufacturing Innovation District Scotland, the £88 million facility features sophisticated GMP environments where new pharmaceutical production methods can be proven at scale.
The University of Texas at El Paso broke ground on the $80 million Advanced Manufacturing and Aerospace Center in late August of 2022. Accommodating courses in additive manufacturing, drone technology, and 3D printing, the 98,000-sf facility will provide the College of Engineering with teaching and research labs, fabrication suites, high bay spaces, classrooms, and administrative offices. The four-story building will feature hands-on learning venues where students can gain the crucial skills needed by local employers such as NASA and Blue Origin.
Thermo Fisher Scientific opened a 300,000-sf viral vector center in August of 2022 in Plainville, Mass. Accelerating the creation of advanced cell and gene therapies, the cGMP-compliant facility offers flexible laboratories and production suites for the development, testing, and manufacture of viral vectors. Featuring Thermo Fisher’s advanced bioprocessing technologies and analytical instrumentation, the sustainably designed structure also includes sophisticated office environments and adjacent warehouse spaces.
Albany College of Pharmacy and Health Sciences Acquires New Home for the Center for Biopharmaceutical Education and Training
Albany College of Pharmacy and Health Sciences has acquired an existing life sciences facility to house the Center for Biopharmaceutical Education and Training. Sited adjacent to the school's campus in Albany, New York, the 154,000-sf structure is uniquely designed for biomedical research with over 60,000 sf of BSL-2 and BSL-3 laboratory space. The five-story building will be renovated to create dedicated gene therapy labs, mammalian cell labs, teaching wet labs, biopharmaceutical pilot plants, and fermentation and downstream processing facilities.
The University of Pennsylvania and Longfellow Real Estate Partners are planning to construct a 455,000-sf life sciences center on the Pennovation Works property in Philadelphia. Designed by Jacobs, the project will include three structures providing a total of 387,000 sf of R&D space and 68,000 sf of biomanufacturing space for the production of cell and gene therapies.